Li Zhang

机构：Peking University, Peking University International Hospital, Changzhou No.2 People's Hospital, Changzhou University · ORCID：0000-0002-6672-4808

发表论文 227 篇 · 总被引 7485 次 · h-index 47

代表论文

• The relationship between the ratio of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol (NHHR) and both MASLD and advanced liver fibrosis: evidence from NHANES 2017–2020 (2025 · Frontiers in Nutrition · 被引 8)
• Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer: final analysis of the randomized RATIONALE-315 trial (2025 · Annals of Oncology · 被引 7)
• Iparomlimab and tuvonralimab (QL1706) plus chemotherapy and bevacizumab for EGFR-mutant patients with advanced non-small cell lung cancer after failure of EGFR-tyrosine kinase inhibitors: updated results from cohort 5 in the DUBHE-L-201 study (2025 · Journal of Hematology & Oncology · 被引 7)
• Application progress of artificial intelligence in tumor diagnosis and treatment (2025 · Frontiers in Artificial Intelligence · 被引 6)
• Safety and Efficacy of the First Subcutaneous ICI , Envafolimab, in the Treatment of Advanced Lung Cancer Patients: A Real‐World Study (2025 · Thoracic Cancer · 被引 5)
• Unveiling the role of c-Met: A promising target for cardiovascular disease (2025 · Pharmacological Research · 被引 4)